Co-Authors
This is a "connection" page, showing publications co-authored by Ole Søgaard and Jacob Bodilsen.
Connection Strength
0.657
-
Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study. Clin Infect Dis. 2021 12 16; 73(12):2283-2293.
Score: 0.246
-
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021 May; 35:100849.
Score: 0.235
-
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study. Clin Infect Dis. 2021 12 06; 73(11):2031-2036.
Score: 0.061
-
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis. Thorax. 2021 04; 76(4):370-379.
Score: 0.057
-
Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study. J Am Heart Assoc. 2020 10 20; 9(19):e017297.
Score: 0.057